Table 3.
Quality assessment criteria | Acharya et al. (2017) | Bajaj et al. (2011) | Bajaj et al. (2013) | Garcia-Martinez et al. (2011) | Hopp et al. (2019) | Nardelli et al. (2017) | Riggio et al. (2011) | Sotil et al. (2009) | Umapathy et al. (2014) | Zarantonello et al. (2019) |
---|---|---|---|---|---|---|---|---|---|---|
Selection | ||||||||||
Representativeness of exposed cohort | * | * | * | * | * | * | * | * | * | * |
Selection of the non-exposed cohort | * | * | * | * | * | * | * | * | * | * |
Ascertainment of exposure | * | * | * | * | * | * | * | * | * | * |
Demonstration that outcome of interest was not present at start of study | – | * | – | - | – | - | – | - | – | – |
Comparability | ||||||||||
Study controls adjusted for main factor? | * | * | * | * | * | * | * | * | * | * |
Study controls adjusted for additional factors? | * | – | * | * | * | – | * | * | – | * |
Outcome | ||||||||||
Assessment ofoutcome | * | * | * | * | * | * | * | * | * | * |
Was follow-up longenough for outcometo occur (2 years) | * | * | * | * | * | * | * | * | * | * |
Adequacy offollow-up ofcohorts? (80%) | * | * | * | * | * | * | * | * | * | * |
Overall Quality Score (Maximum: 9) | 8 | 8 | 8 | 8 | 8 | 7 | 8 | 8 | 7 | 8 |
The studies receiving at least six stars (maximum of nine) were classified as good quality.